| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sagimet Biosciences Inc. | General Counsel and CCO | Series A Common Stock | 171K | $703K | $4.10 | Nov 17, 2023 | Direct |
| Sagimet Biosciences Inc. | General Counsel and CCO | Series A Common Stock | 161K | $498K | $3.10 | Jul 19, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SGMT | Sagimet Biosciences Inc. | Jul 19, 2024 | 1 | -$33.8K | 4 | Jul 23, 2024 | General Counsel and CCO |
| SGMT | Sagimet Biosciences Inc. | Nov 17, 2023 | 1 | $0 | 4 | Nov 21, 2023 | General Counsel and CCO |
| SGMT | Sagimet Biosciences Inc. | Jul 18, 2023 | 2 | $0 | 4 | Jul 20, 2023 | General Counsel and CCO |
| SGMT | Sagimet Biosciences Inc. | Jul 13, 2023 | 0 | $0 | 3 | Jul 13, 2023 | General Counsel and CCO |